Endovascular Treatment of Acute Abdominal Aortic Thrombosis after Cisplatin-Based ChemotherapyHaruhiko Akagi1*, Hiroshi Irie1, Yoshihisa Nakao1, Mitsunori Kaneko1, Kei Sakai1 and Shoji Sakaguchi2
- *Corresponding Author:
- Haruhiko Akagi
Department of Cardiovascular Surgery
Yao Tokushukai General Hospital, 1-17
Wakakusacho, Yao-shi, Osaka, 581-0011, Japan
E-mail: [email protected]
Received Date: July 27, 2013; Accepted Date: August 08, 2013; Published Date: August 10, 2013
Citation: Akagi H, Irie H, Nakao Y, Kaneko M, Sakai K, et al. (2013) Endovascular Treatment of Acute Abdominal Aortic Thrombosis after Cisplatin-Based Chemotherapy. J Vasc Med Surg 1:111. doi: 10.4172/2329-6925.1000111
Copyright: © 2013 Akagi H, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
A 75-year-old male received preoperative cisplatin-based adjuvant chemotherapy for advanced gastric cancer. Three days after administration of cysplatin, the patient presented severe abdominal pain and calf claudication. A multi detector computed tomography (MDCT) revealed a floating mass in the infrarenal abdominal aorta. Considering the underlying malignant disease and subsequent laparotomy, we adopted endovascular treatment as a less invasive treatment: Fogarty thrombectomy followed by stent graft exclusion. Although cisplatin-based chemotherapy is known to be a high risk thromboembolic event, acute thrombosis of the aorta is exceedingly rare and its standard therapeutic management is not well established. We believe this procedure will prove to be a reliable less invasive treatment for this entity in cases of high-risk, such as with cancer patients.